- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Cdc7-inhibitor (BMS-863233)
Total 1690 results
-
Bristol-Myers SquibbCompletedChronic Myeloid LeukemiaAustralia, Italy, Canada, United States, Germany, Spain, France
-
Bristol-Myers SquibbCompletedMelanoma | Non-Small Cell Lung Cancer | Advanced CancerCanada, United States, Australia, France, Italy, Spain, Finland, Germany, Norway, Poland, Sweden
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
University of ChicagoBristol-Myers SquibbCompletedCancerUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsUnited States, Chile, Argentina, Belgium, Canada, Japan, Netherlands
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Belgium, Canada
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsSpain, United States, Netherlands, France, Italy, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingHead and Neck Squamous Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
Bristol-Myers SquibbTerminatedHepatocellular CarcinomaCanada, Singapore, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerFrance, United States, Spain, Canada, Argentina, Chile, Italy
-
Bristol-Myers SquibbCompletedAdvanced TumorsUnited States, France, Australia, Spain, Canada
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbTerminatedAdvanced Solid Tumors | Advanced B-cell NHLUnited States, France, Spain, Germany
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung Cancer | Lung CancerItaly, Korea, Republic of, Turkey, Canada, Spain, Australia, Mexico, Taiwan, France, Germany, Switzerland, Greece, Japan, Austria, United States, Brazil, Czechia
-
David Bond, MDBristol-Myers SquibbActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
Bristol-Myers SquibbCompletedAtrial Fibrillation | Atrial FlutterAustralia, Brazil, China, France, Germany, India, Italy, Korea, Republic of, Mexico, Russian Federation, Sweden, Taiwan, Turkey, United States, Hong Kong, Spain, Argentina, Canada, Puerto Rico, Colombia, Denmark, Austria, Belgium, Hun... and more
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Bristol-Myers SquibbCompletedAdvanced Solid TumorsChina
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruiting
-
Bristol-Myers SquibbRoche-GenentechTerminated
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbMedarexCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingHepatocellular CarcinomaUnited States
-
AstraZenecaCompletedType 2 Diabetes Mellitus
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
Incyte CorporationTerminated
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Carcinoma in the Liver | Metastatic Carcinoma in the Lung | Metastatic Malignant Neoplasm in the Thoracic CavityUnited States
-
M.D. Anderson Cancer CenterRecruitingRenal Medullary Carcinoma | CarcinomasUnited States
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedUrothelial CarcinomaNetherlands
-
Bristol-Myers SquibbCompletedPan TumorUnited States, Puerto Rico, Italy, Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Netherlands, Poland, Romania, Singapore, Spain, United Kingdom
-
Bristol-Myers SquibbCompletedVarious Advanced CancerUnited States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Metastatic Melanoma | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostrate CancerUnited States
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada
-
Georgetown UniversityBristol-Myers Squibb; M.D. Anderson Cancer Center; University of Colorado, Denver and other collaboratorsTerminatedMucosal Melanoma | Acral Lentiginous MelanomaUnited States
-
Melanoma Institute AustraliaBristol-Myers Squibb; Melanoma and Skin Cancer Trials LimitedActive, not recruitingMelanoma | Brain MetastasesAustralia
-
University of Michigan Rogel Cancer CenterBristol-Myers SquibbCompletedPeripheral T Cell LymphomaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, Peru, Romania, Colombia, South Africa, Germany, Russian Federation, Argentina, Mexico
-
Bristol-Myers SquibbTerminated
-
Yvonne EfeberaBristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Dan ZandbergBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States